<!DOCTYPE HTML>
<!-- saved from url=(0074)http://adp-dhanes/Nchs/Edit/DocumentationView.aspx -->
<!DOCTYPE html PUBLIC "" ""><HTML lang="en" lang="en" xml:lang="en" xmlns="http://www.w3c.org/1999/xhtml"><HEAD><META 
content="IE=11.0000" http-equiv="X-UA-Compatible">
     
<META http-equiv="content-type" content="text/html; charset=utf-8">     
<TITLE>FOLATE_E</TITLE>     
<META name="title" content="NHANES 2007-2008: Folate - RBC &amp; Serum Data Documentation, Codebook, and Frequencies"> 
    
<STYLE type="text/css">
					.nhanes-doc { font: 75% Verdana, Arial, Helvetica, sans-serif; }

					.nhanes-doc h1 {
					color: #0c5205;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 2em;
					font-weight: normal;
					margin-bottom: 10px;
					margin-top: 0;
					}

					.nhanes-doc h2 {
					color: #0c5205;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.6em;
					font-weight: normal;
					}

					.nhanes-doc h3 {
					color: #000;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.5em;
					font-weight: normal;
					}

					.nhanes-doc h3.vartitle {
					background-color: #c1d5b0;
					padding: 6px 12px;
					}

					.nhanes-doc h4 {
					color: #000;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.3em;
					font-weight: bold;
					}

					.nhanes-doc h5 {
					color: #000;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1em;
					font-weight: bold;
					}

					.nhanes-doc h5.specialnote {
					color: #000;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1.2em;
					font-style: italic;
					font-weight: bold;
					}

					.nhanes-doc a {
					color: #039;
					text-decoration: none;
					}

					.nhanes-doc p {
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1em;
					line-height: 1.33em;
					margin: 0 3em 1em;
					padding: 0;
					text-align: left;
					}

					.nhanes-doc ul {
					list-style-type: disc;
					margin: 0 3em 1em;
					padding: 0;
					}

					.nhanes-doc ol {
					list-style-type: decimal;
					margin: 0;
					overflow: hidden;
					padding: 0;
					padding-left: 2em;
					}

					.nhanes-doc li {
					margin-left: 1.5em;
					margin-top: 0.7em;
					}

					.nhanes-doc table {
					border: #000 1px solid;
					border-collapse: collapse;
					margin: 0 auto 1em;
					max-width: 600px;
					padding: 2px;
					page-break-inside: avoid;
					table-layout: auto;
					}

					.nhanes-doc th {
					background: #f4f4e1;
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: center;
					vertical-align: top;
					}

					.nhanes-doc th.rowheader {
					background: #f4f4e1;
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: center;
					vertical-align: top;
					}

					.nhanes-doc td {
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: left;
					vertical-align: top;
					}

					.nhanes-doc td.values2 {
					text-align: RIGHT;
					vertical-align: top;
					}

					.nhanes-doc table caption {
					font-weight: bold;
					padding-bottom: 0.5em;
					}

					.nhanes-doc div#wrapper { width: 650px; }

					.nhanes-doc div#toc {
					border: solid 1px #CCC;
					float: left;
					height: 95%;
					left: 750px;
					overflow: hidden;
					position: fixed;
					top: 10px;
					width: 400px;
					z-index: 10;
					}

					.nhanes-doc div#toc h3 {
					background-color: #f4f4e1;
					border-bottom: solid 1px #ccc;
					letter-spacing: 8px;
					margin: 0;
					padding: 8px;
					text-align: center;
					text-transform: uppercase;
					}

					.nhanes-doc div#toc-scroll {
					height: calc(100% - 1.5em);
					overflow: scroll;
					width: 100%;
					}

					.nhanes-doc div#toc li {
					margin-left: -0.5em;
					margin-right: -0.5em;
					}

					.nhanes-doc div#PageHeader {
					border-bottom: thin solid #999;
					margin-bottom: 12px;
					width: 650px;
					}

					.nhanes-doc div#Sections { width: 650px; }

					.nhanes-doc div#Codebook { width: 650px; }

					.nhanes-doc div#Codebook dl {
					margin: 2em 0 10px 40px;
					padding: 0;
					width: 600px;
					display: table;
					}

					.nhanes-doc div#Codebook dt {
					float: left;
					font-weight: bold;
					margin: 0;
					padding: 0.5em;
					width: 150px;
					display: table-cell;
					}

					.nhanes-doc div#Codebook dd {
					float: left;
					margin: 0;
					padding: 0.5em;
					width: 420px;
					display: table-cell;
					}

					.nhanes-doc div#References {
					page-break-after: always;
					width: 650px;
					}

					.nhanes-doc div#Appendix {
					page-break-after: always;
					width: 650px;
					}

					.nhanes-doc table.values {
					border: 2px;
					left: 20px;
					margin-bottom: 20px;
					page-break-inside: avoid;
					position: relative;
					width: 600px;
					}

					.nhanes-doc span.file-size { color: gray; }

					.nhanes-doc .pagebreak {
					background-color: transparent;
					display: block;
					page-break-after: always;
					page-break-inside: avoid;
					}
				</STYLE>
     
<STYLE type="text/css" media="print">
					.nhanes-doc div#toc { display: none; }
				</STYLE>
   
<META name="GENERATOR" content="MSHTML 11.00.10570.1001"></HEAD>   
<BODY class="nhanes-doc">
<DIV id="toc">
<H3>Table of Contents</H3>
<DIV id="toc-scroll">
<UL>
  <LI><A href="http://adp-dhanes/Nchs/Edit/DocumentationView.aspx?Id=856&amp;Dataset=FOLATE_E#Component_Description">Component 
  Description</A>           </LI>
  <LI><A href="http://adp-dhanes/Nchs/Edit/DocumentationView.aspx?Id=856&amp;Dataset=FOLATE_E#Eligible_Sample">Eligible 
  Sample</A>           </LI>
  <LI><A href="http://adp-dhanes/Nchs/Edit/DocumentationView.aspx?Id=856&amp;Dataset=FOLATE_E#Description_of_Laboratory_Methodology">Description 
  of Laboratory Methodology</A>           </LI>
  <LI><A href="http://adp-dhanes/Nchs/Edit/DocumentationView.aspx?Id=856&amp;Dataset=FOLATE_E#Laboratory_Method_Files">Laboratory 
  Method Files</A>           </LI>
  <LI><A href="http://adp-dhanes/Nchs/Edit/DocumentationView.aspx?Id=856&amp;Dataset=FOLATE_E#Laboratory_Quality_Assurance_and_Monitoring">Laboratory 
  Quality Assurance and Monitoring</A>           </LI>
  <LI><A href="http://adp-dhanes/Nchs/Edit/DocumentationView.aspx?Id=856&amp;Dataset=FOLATE_E#Data_Processing_and_Editing">Data 
  Processing and Editing</A>           </LI>
  <LI><A href="http://adp-dhanes/Nchs/Edit/DocumentationView.aspx?Id=856&amp;Dataset=FOLATE_E#Analytic_Notes">Analytic 
  Notes</A>           </LI>
  <LI><A href="http://adp-dhanes/Nchs/Edit/DocumentationView.aspx?Id=856&amp;Dataset=FOLATE_E#References">References</A> 
            </LI>
  <LI><A href="http://adp-dhanes/Nchs/Edit/DocumentationView.aspx?Id=856&amp;Dataset=FOLATE_E#Codebook">Codebook</A> 
              
  <UL id="CodebookLinks">
    <LI><A href="http://adp-dhanes/Nchs/Edit/DocumentationView.aspx?Id=856&amp;Dataset=FOLATE_E#SEQN">SEQN 
    - Respondent sequence number</A>               </LI>
    <LI><A href="http://adp-dhanes/Nchs/Edit/DocumentationView.aspx?Id=856&amp;Dataset=FOLATE_E#LBDRBF">LBDRBF 
    - RBC folate (ng/mL)</A>               </LI>
    <LI><A href="http://adp-dhanes/Nchs/Edit/DocumentationView.aspx?Id=856&amp;Dataset=FOLATE_E#LBXRBFSI">LBXRBFSI 
    - RBC folate (nmol/L)</A>               </LI>
    <LI><A href="http://adp-dhanes/Nchs/Edit/DocumentationView.aspx?Id=856&amp;Dataset=FOLATE_E#LBDFOL">LBDFOL 
    - Serum folate (ng/mL)</A>               </LI>
    <LI><A href="http://adp-dhanes/Nchs/Edit/DocumentationView.aspx?Id=856&amp;Dataset=FOLATE_E#LBXFOLSI">LBXFOLSI 
    - Serum folate ( nmol/L)</A>               </LI></UL></LI></UL></DIV></DIV>
<DIV id="wrapper">
<DIV id="PageHeader">
<H1>National Health and Nutrition Examination Survey</H1>
<H2>2007-2008 Data Documentation, Codebook, and Frequencies</H2>
<H3>Folate - RBC &amp; Serum (FOLATE_E)</H3>
<H4> Data File: FOLATE_E.xpt</H4>
<H5 class="left">First Published: June 2011</H5>
<H5 class="right">Last Revised: NA</H5></DIV>
<DIV id="Sections">
<H2 id="Component_Description">Component Description</H2>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The objectives of this 
component are to: 1) provide data for monitoring secular trends in measures of 
nutritional status in the U.S. population; 2) evaluate the effect of people's 
habits and behaviors, such as physical activity and the use of alcohol, tobacco, 
and dietary supplements on nutritional status; and 3) evaluate the effect of 
changes in nutrition and public health policies including welfare reform 
legislation, food fortification policy, and child nutrition programs on the 
nutritional status of the U.S. population. </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">These data will be used 
to estimate deficiencies and toxicities of specific nutrients in the population 
and subgroup, to provide population reference data, and to estimate the 
contribution of diet, supplements, and other factors to serum levels of
 nutrients. Data will be used in research to further define nutrient
 requirements as well as optimal levels for disease prevention and health
 promotion. <A name="Eligible_Sample"></A>&nbsp;</P>
<H2 id="Eligible_Sample">Eligible Sample</H2>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Examined participants
 aged 1 year and older were eligible. </P>
<H2 id="Description_of_Laboratory_Methodology">Description of Laboratory 
Methodology</H2>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">In NHANES 2007-2008,
 population folate status was assessed by measuring serum folate and whole-blood
 folate by microbiologic assay and by calculating RBC folate using these data. 
Microbiological assays have been used for many years to estimate the
 concentration of folate in blood and other tissues. In the 1990s, more robust
 and reliable procedures that use microtiter plates for higher throughput and a
 cryopreserved antibiotic resistant microorganism to avoid having to work under
 aseptic conditions were developed. The described procedure is an adaptation of
 such a method, and was introduced by the National Center for Environmental
 Health (NCEH) to NHANES in 2007. Diluted serum or whole blood is added to an
 assay medium containing Lactobacillus rhamnosus (formerly known as 
<I></I>Lactobacillus casei) (NCIB 10463) and all of the nutrients necessary for 
the growth of L. rhamnosus except folate. The inoculated medium is incubated for 
45 hours at 37<SUP>o</SUP>C. Since the growth of L. rhamnosus is proportional to 
the amount of total folate present in serum or whole blood samples; the folate 
level can be assessed by measuring the turbidity of the inoculated medium at 590 
nm in a PowerWave X340 Microplate reader (Bio-Tek Instrument). The assay was 
calibrated with 5-methyl-tetrahydrofolate from Merck Cie (Eprova). </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">There were no changes 
to the lab method, lab equipment, or lab site for this component within the 
NHANES 2007-2008 cycle. However, there were changes from the previous 2 years of 
NHANES to equipment, and lab method. In 2005-2006, RBC folates and serum folates 
were measured using the Bio-Rad Laboratories "Quantaphase II Folate" radioassay 
kit. As mentioned above, in 2007-2008, RBC folates and serum folates were 
measured using the microbiologic assay. </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Refer to the Laboratory 
Method Files section for detailed description on the laboratory methods 
used.&nbsp; <BR></P>
<H2 id="Laboratory_Method_Files">Laboratory Method Files</H2>
<P><A href="https://wwwn.cdc.gov/nchs/data/nhanes/2007-2008/labmethods/FOLATE_E_MET.PDF" 
target="_blank">Whole Blood and Serum Folate</A>           <SPAN> (May 
2013)</SPAN>         </P>
<H2 id="Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality 
Assurance and Monitoring</H2>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Whole blood and blood
 serum are processed, stored, and shipped to the Division of Laboratory 
Sciences, National Center for Environmental Health, Centers for Disease Control 
and Prevention, Atlanta, GA for analysis. </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Detailed instructions 
on specimen collection and processing are discussed in the <A href="https://wwwn.cdc.gov/nchs/data/nhanes/2007-2008/manuals/manual_lab.pdf">NHANES
 Laboratory Procedure Manual (LPM)</A>. Vials are stored under appropriate 
frozen (-20<SUP>o</SUP>C) conditions until they are shipped to National Center 
for Environmental Health for testing. </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The NHANES quality
 assurance and quality control (QA/QC) protocols meet the 1988 Clinical
 Laboratory Improvement Act mandates. Detailed QA/QC instructions are discussed
 in the <A href="https://wwwn.cdc.gov/nchs/data/nhanes/2007-2008/manuals/manual_lab.pdf">NHANES 
LPM</A>. <BR><BR><B style="mso-bidi-font-weight: normal;">Mobile Examination
 Centers (MECs)</B><B style="mso-bidi-font-weight: normal;"> </B></P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Laboratory team 
performance is monitored using several techniques. NCHS and contract consultants 
use a structured quality assurance evaluation during unscheduled visits to 
evaluate both the quality of the laboratory work and the quality-control 
procedures. Each laboratory staff member is observed for equipment operation, 
specimen collection and preparation; testing procedures and constructive 
feedback are given to each staff member. Formal retraining sessions are 
conducted annually to ensure that required skill levels were maintained. </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><B style="mso-bidi-font-weight: normal;">Analytical
 Laboratories</B><B> </B></P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">NHANES uses several 
methods to monitor the quality of the analyses performed by the contract
 laboratories. In the MEC, these methods include performing blind split samples 
collected during “dry run” sessions. In addition, contract laboratories randomly 
perform repeat testing on 2% of all specimens. </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">NCHS developed and 
distributed a quality control protocol for all the contract laboratories, which 
outlined the use of Westgard rules (Westgard, et al. 1981) when running NHANES 
specimens. Progress reports containing any problems encountered during shipping 
or receipt of specimens, summary statistics for each control pool, QC graphs, 
instrument calibration, reagents, and any special considerations are submitted 
to NCHS quarterly. The reports are reviewed for trends or shifts in the data. 
The laboratories are required to explain any identified areas of concern.
&nbsp; </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">All QC procedures 
recommended by the manufacturers were followed. Reported results for all assays 
meet the Division of Laboratory Sciences’ quality control and quality assurance 
performance criteria for accuracy and precision, similar to the Westgard rules 
(Caudill, et al. 2008).&nbsp;&nbsp;<BR></P>
<H2 id="Data_Processing_and_Editing">Data Processing and Editing</H2>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The data were reviewed. 
&nbsp;Incomplete data or improbable values were sent to the performing 
laboratory for confirmation. </P>
<P style="margin: 0in 0in 10pt 0.5in; line-height: normal; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-outline-level: 2;">Two 
derived variables were created in this data file. The variables were created 
using the following formula:</P>
<P style="margin: 0in 0in 10pt 0.5in;"><B 
style="mso-bidi-font-weight: normal;">LBDRBF</B>: The RBC folate value in nmol/L 
RBC (LBXRBFSI) was converted to ng/mL RBC (LBDRBF) by dividing LBXRBFSI by 2.265 
(rounded to 1 decimal).</P>
<P style="margin: 0in 0in 10pt 0.5in;"><STRONG>LBDFOL</STRONG>: The serum folate 
value in nmol/L (LBXFOLSI) was converted to ng/mL (LBDFOL) by dividing LBXFOLSI 
by 2.265 (rounded to 1 decimal).</P><BR>
<H2 id="Analytic_Notes">Analytic Notes</H2>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Refer to the <A href="https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/overviewlab.aspx?BeginYear=2007"><SPAN 
style="color: rgb(0, 0, 255);">2007-2008 Laboratory Data Overview</SPAN></A> for 
general information on NHANES laboratory data. </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Examined sample weights 
should be used for analyses. Please refer to the <A href="https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx">NHANES 
Analytic Guidelines</A> and the on-line <A href="https://www.cdc.gov/nchs/tutorials/">NHANES 
Tutorial</A> for&nbsp;details on the use of sample weights and other analytic 
issues. </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><B>Demographic and
 Other Related Variables</B> </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The analysis of NHANES 
laboratory data must be conducted using the appropriate survey design and 
demographic variables. The <A href="https://wwwn.cdc.gov/nchs/nhanes/search/datapage.aspx?Component=Demographics&amp;CycleBeginYear=2007">NHANES 
2007-2008 Demographics File</A> contains demographic data, health indicators, 
and other related information collected during household interviews as well as 
the sample design variables. The recommended procedure for variance estimation 
requires use of stratum and PSU variables (SDMVSTRA and SDMVPSU, respectively) 
in the demographic data file. </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The <A href="https://wwwn.cdc.gov/nchs/nhanes/2007-2008/fastqx_e.htm">Fasting
 Questionnaire File</A> includes auxiliary information such as fasting status, 
the time of venipuncture, and the conditions precluding venipuncture. </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">This laboratory data 
file can be linked to the other NHANES data files using the unique survey 
participant identifier (i.e., SEQN). </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><B>Detection Limits 
</B></P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">An exact lower limit of
 detection (LLOD) for RBC folate cannot be calculated because the value is a 
composite of whole blood folate, serum folate and hematocrit. Therefore, there 
is no LLOD for the calculated value of RBC folate. Furthermore, the LOD of this 
method for serum folate and whole blood folate depends on the dilution factor 
(i.e., LOD = 1 nmol/L if serum is only diluted 1/20). </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><B>Serum Folate
 Regression Equations to Compare 2007-2008 and 1999-2006 Data</B></P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><B><SPAN style="text-decoration: underline;">Background:</SPAN></B></P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">There was a change in 
serum folate methods from 1999-2006 to 2007-2008. In 1999-2006, serum folate was 
performed using the Bio-Rad (BR) Quantaphase II radioassay. In 2007-2008, serum 
folate was measured using a microbiological assay (MA). Serum folate levels were 
much higher in 2007-2008 using the MA method compared with previous data
 (1999-2006) using the BR method. There are two variables for serum folate: one
 expressed in conventional units (ng/mL) and one in SI units (nmol/L). For
 1999-2006, they were LBXFOL (ng/mL) and LBDFOLSI (nmol/L), and for 2007-2008,
 they were LBDFOL (ng/mL) and LBXFOLSI (nmol/L). To convert conventional units
 (ng/mL) to SI units (nmol/L), multiply by 2.265. </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">A crossover study was 
performed between the BR and MA methods by the CDC laboratory as described by 
Fazili et al. (Fazili Z, et al. 2007). Several regression methods were examined 
to relate the BR assay and the MA including linear, Deming, piecewise linear, 
and fractional polynomial. The fractional polynomial regression method best fit 
the Fazili crossover data. The forward fractional polynomial regression equation 
is recommended to trend the serum folate data since the MA method is a more 
accurate “gold standard” method and the BR method is no longer available. </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><B><SPAN style="text-decoration: underline;">Forward 
regression of 1999-2006 BR results (nmol/L) to match 2007-2008 MA results 
(nmol/L): </SPAN></B></P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Convert the 1999-2006 
BR serum folate (FOL, nmol/L) results to 2007-2008 equivalent values to match 
the MA serum folate (FOL<SUB>adjusted</SUB>, nmol/L) results using the following 
fractional polynomial regression equation: </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">FOL<SUB>adjusted</SUB> 
= 10**(0.0188 * x<SUP>3 </SUP>- 2.7109 * x<SUP>-1/2</SUP> + 3.8276), where X = 
Log<SUB>10</SUB>FOL </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><B><SPAN style="text-decoration: underline;">Example
 calculation:</SPAN></B><B style="mso-bidi-font-weight: normal;"><SPAN style="text-decoration: underline;"> 
</SPAN></B></P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">For NHANES 2005-2006, 
sequence number (SEQN) = 31128, serum folate (LBDFOLSI) = 30.4 nmol/L </P>
<P style="margin: 0in 0.5in 0pt; line-height: 15.95pt;">FOL<SUB>adjusted </SUB>= 
10**[0.0188 * (Log<SUB>10</SUB>30.4)<SUP>3 </SUP>– 2.7109 * 
(Log<SUB>10</SUB>30.4)<SUP>-1/2</SUP> + 3.8276] <BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
= 10**(0.0188 * 1.48287<SUP>3</SUP> – 2.7109 * 1.48287<SUP>-1/2</SUP> + 3.8276) 
</P>
<P 
style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
= 45.9955 <BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
= 46 nmol/L <BR><BR><B>Red Blood Cell Folate - Comparison of 2007-2008 and 
1999-2006 Data<SPAN style="text-decoration: underline;"></SPAN></B></P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><B><SPAN style="text-decoration: underline;">Background: 
</SPAN></B><BR>There was a change in red blood cell (RBC) folate methods from 
1999-2006 to 2007-2008. In 1999-2006, RBC folate measurements were performed 
using the Bio-Rad (BR) Quanta Phase II radioassay. In 2007-2008, RBC folate was 
measured using a microbiological assay (MA). RBC folate levels were much higher 
in 2007-2008 using the MA method compared with previous data (1999-2006) using 
the BR method. There are two variables for RBC folate: one expressed in 
conventional units (ng/mL) and one in SI units (nmol/L). For 1999-2006, they 
were LBXRBF (ng/mL) and LBDRBFSI (nmol/L), and for 2007-2008, they were LBDRBF 
(ng/mL) and LBXRBFSI (nmol/L). To convert conventional units (ng/mL) to SI units 
(nmol/L), multiply by 2.265. </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">A crossover study for 
whole blood folate (WBF) was performed between the BR and MA assays by the CDC 
laboratory as described by Fazili et al. (Fazili Z, et al. 2008). The authors 
showed that while the WBF values for the BR assay measured lower than the MA 
(average 45%), there was a different relationship between the two assays
 depending on the 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T
 polymorphism. Whole blood samples from persons with the T/T genotype showed a
 smaller difference between the two assays (average 31%) compared to whole blood
 samples from persons with the C/C and C/T genotype (average 48%). The reason
 for this was that the BR assay recovered the various folate forms differently
 compared to the MA assay. </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The MTHFR genotype
 information is not available for NHANES 1999-2008 and the genotype-specific
 regression equations reported by Fazili et al. cannot be used. Using the
 crossover data for all genotypes presented in the Fazili et al. paper, several
 regression methods were evaluated to relate the BR assay and the MA method for
 the WBF data for 1999-2008. These regression methods included the linear,
 Deming, piecewise linear, and fractional polynomial models. The linear
 regression model for WBF best fit the Fazili crossover data. As presented in
 the analytic note on serum folate, the fractional polynomial regression model
 was applied to adjust the serum folate data. This was necessary because serum
 folate is part of the equation to calculate RBC folate. A forward regression
 model is recommended to trend the RBC folate data since the MA method is
 considered a more accurate “gold standard” method and the BR method is no
 longer available. </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><B><SPAN style="text-decoration: underline;">Forward 
regression of 1999-2006 BR results (nmol/L) to match 2007-2008 MA results 
(nmol/L):</SPAN></B> </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">Since the Fazili
 crossover study presents WBF data rather than RBC folate data, it is necessary
 to first convert RBC folate data to WBF data before applying any regression
 equation to make the data sets comparable. </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The following algorithm 
is recommended: <BR>1) Convert the 1999-2006 BR RBC folate (RBF, nmol/L) to 
whole-blood folate (WBF, nmol/L) using the hematocrit (HCT, %) and the BR serum 
folate (FOL, nmol/L) in the following equation: </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">WBF = (RBF * HCT/100) + 
FOL * [1.0 - (HCT/100)] </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The hematocrit can be 
obtained from the NHANES hematology files containing the complete blood count. 
</P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">2) Apply the following 
forward linear regression to obtain an adjusted WBF (WBF<SUB>adjusted</SUB>) 
using WBF from step 1 to match the 2007-2008 MA WBF: </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">WBF<SUB>adjusted</SUB> 
= 10**[0.2204 + (1.017 * Log<SUB>10</SUB>WBF)] </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">3) Convert the
 1999-2006 BR serum folate (FOL, nmol/L) results to 2007-2008 equivalent values
 to match the MA serum folate (FOL<SUB>adjusted</SUB>, nmol/L) results using the 
forward fractional polynomial regression equation specified in the analytic note 
on serum folate: </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">FOL<SUB>adjusted</SUB> 
= 10**(0.0188 * X<SUP>3</SUP> – 2.7109 * X<SUP>-1/2</SUP> + 3.8276), where X = 
Log<SUB>10</SUB>FOL</P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">4) Calculate 
RBF<SUB>adjusted</SUB> by using WBF<SUB>adjusted</SUB> (from step 2) and
 FOL<SUB>adjusted</SUB> (from step 3): </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">RBF<SUB>adjusted 
</SUB>= {WBF<SUB>adjusted</SUB> – [FOL<SUB>adjusted</SUB> * (1.0 - (HCT/100))]} 
/ (HCT/100) </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">The analyst is
 cautioned that trending RBC folate by this procedure does not use
 genotype-specific equations as the MTHFR genotype was not determined in NHANES.
 This may slightly underestimate RBC folate concentrations for some participants
 and overestimate concentrations for others. </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;"><B><SPAN style="text-decoration: underline;">Example
 calculation: </SPAN></B></P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">1) WBF = (378.3*
 41.4/100) + 30.4 * [1.0 - (41.4/100)] <BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; = 174.4306
 nmol/L </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">2) WBF<SUB>adjusted 
</SUB>= 10**(0.2204 + 1.017 * Log<SUB>10</SUB>174.4306) <BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
= 10**(0.2204 + 1.017 * 2.24162) <BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
= 316.323 nmol/L </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">3) FOL<SUB>adjusted 
</SUB>= 10**[0.0188 * (Log<SUB>10</SUB>30.4)<SUP>3 </SUP>– 2.7109 * 
(Log<SUB>10</SUB>30.4)<SUP>-1/2</SUP> + 3.8276] <BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
= 10**(0.0188 * 1.48287<SUP>3</SUP> – 2.7109 * 1.48287<SUP>-1/2</SUP> + 3.8276) 
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
= 45.9955 nmol/L </P>
<P style="margin: 0in 0.5in 12pt; line-height: 15.95pt;">4) 
RBF<SUB>adjusted</SUB> = {316.323 – [45.9955 * (1.0 - (41.4/100))]} / (41.4/100) 
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
≈ 699 nmol/L </P><BR></DIV>
<DIV id="References">
<H2>References</H2>
<UL>
  <LI>Caudill, S.P., Schleicher, R.L., Pirkle, J.L. Multi-rule quality control 
  for the age-related eye disease study. Statist Med (2008); 
  27(20):4094-40106.</LI>
  <LI>Fazili Z, Pfeiffer CM, Zhang M, Jain RB, Koontz D. Influence of 
  5,10-methylenetetrahydrofolate reductase polymorphism on whole-blood folate 
  concentrations measured by LC-MS/MS, microbiologic assay, and Bio-Rad 
  radioassay. Clin Chem (2008); 54(1):197-201.</LI>
  <LI>Fazili Z, Pfeiffer CM, Zhang M. Comparison of serum folate species 
  analyzed by LC-MS/MS with total folate measured by microbiological assay and 
  Bio-Rad assay. Clin Chem (2007); 53(4):781-4.</LI>
  <LI>Westgard J.O., Barry P.L., Hunt M.R., Groth T. A multi-rule Shewhart chart 
  for quality control in clinical chemistry. Clin Chem (1981); 
27:493-501.</LI></UL></DIV>
<DIV id="Codebook">
<H2>Codebook and Frequencies</H2>
<DIV class="pagebreak">
<H3 class="vartitle" id="SEQN">SEQN - Respondent sequence number</H3>
<DL>
  <DT>Variable Name: </DT>
  <DD class="info">SEQN</DD>
  <DT>SAS Label: </DT>
  <DD>Respondent sequence number</DD>
  <DT>English Text: </DT>
  <DD class="info">Respondent sequence number.</DD>
  <DT>Target: </DT>
  <DD> Both males and females 1 YEARS -			150 YEARS</DD></DL></DIV>
<DIV class="pagebreak">
<H3 class="vartitle" id="LBDRBF">LBDRBF - RBC folate (ng/mL)</H3>
<DL>
  <DT>Variable Name: </DT>
  <DD class="info">LBDRBF</DD>
  <DT>SAS Label: </DT>
  <DD>RBC folate (ng/mL)</DD>
  <DT>English Text: </DT>
  <DD class="info">RBC folate (ng/mL)</DD>
  <DT>Target: </DT>
  <DD> Both males and females 1 YEARS -			150 YEARS</DD></DL>
<TABLE class="values">
  <THEAD>
  <TR>
    <TH class="values" scope="column">Code or Value</TH>
    <TH class="values" scope="column">Value Description</TH>
    <TH class="values" scope="column">Count</TH>
    <TH class="values" scope="column">Cumulative</TH>
    <TH class="values" scope="column">Skip to Item</TH></TR></THEAD>
  <TBODY>
  <TR>
    <TD class="values" scope="row">85.7 to 2984.5</TD>
    <TD class="values">Range of Values</TD>
    <TD align="right" class="values">8243</TD>
    <TD align="right" class="values">8243</TD>
    <TD class="values"></TD></TR>
  <TR>
    <TD class="values" scope="row">.</TD>
    <TD class="values">Missing</TD>
    <TD align="right" class="values">1064</TD>
    <TD align="right" class="values">9307</TD>
    <TD class="values"></TD></TR></TBODY></TABLE></DIV>
<DIV class="pagebreak">
<H3 class="vartitle" id="LBXRBFSI">LBXRBFSI - RBC folate (nmol/L)</H3>
<DL>
  <DT>Variable Name: </DT>
  <DD class="info">LBXRBFSI</DD>
  <DT>SAS Label: </DT>
  <DD>RBC folate (nmol/L)</DD>
  <DT>English Text: </DT>
  <DD class="info">RBC folate (nmol/L)</DD>
  <DT>Target: </DT>
  <DD> Both males and females 1 YEARS -			150 YEARS</DD></DL>
<TABLE class="values">
  <THEAD>
  <TR>
    <TH class="values" scope="column">Code or Value</TH>
    <TH class="values" scope="column">Value Description</TH>
    <TH class="values" scope="column">Count</TH>
    <TH class="values" scope="column">Cumulative</TH>
    <TH class="values" scope="column">Skip to Item</TH></TR></THEAD>
  <TBODY>
  <TR>
    <TD class="values" scope="row">194 to 6760</TD>
    <TD class="values">Range of Values</TD>
    <TD align="right" class="values">8243</TD>
    <TD align="right" class="values">8243</TD>
    <TD class="values"></TD></TR>
  <TR>
    <TD class="values" scope="row">.</TD>
    <TD class="values">Missing</TD>
    <TD align="right" class="values">1064</TD>
    <TD align="right" class="values">9307</TD>
    <TD class="values"></TD></TR></TBODY></TABLE></DIV>
<DIV class="pagebreak">
<H3 class="vartitle" id="LBDFOL">LBDFOL - Serum folate (ng/mL)</H3>
<DL>
  <DT>Variable Name: </DT>
  <DD class="info">LBDFOL</DD>
  <DT>SAS Label: </DT>
  <DD>Serum folate (ng/mL)</DD>
  <DT>English Text: </DT>
  <DD class="info">Serum folate (ng/mL)</DD>
  <DT>Target: </DT>
  <DD> Both males and females 1 YEARS -			150 YEARS</DD></DL>
<TABLE class="values">
  <THEAD>
  <TR>
    <TH class="values" scope="column">Code or Value</TH>
    <TH class="values" scope="column">Value Description</TH>
    <TH class="values" scope="column">Count</TH>
    <TH class="values" scope="column">Cumulative</TH>
    <TH class="values" scope="column">Skip to Item</TH></TR></THEAD>
  <TBODY>
  <TR>
    <TD class="values" scope="row">2.2 to 209.3</TD>
    <TD class="values">Range of Values</TD>
    <TD align="right" class="values">8205</TD>
    <TD align="right" class="values">8205</TD>
    <TD class="values"></TD></TR>
  <TR>
    <TD class="values" scope="row">.</TD>
    <TD class="values">Missing</TD>
    <TD align="right" class="values">1102</TD>
    <TD align="right" class="values">9307</TD>
    <TD class="values"></TD></TR></TBODY></TABLE></DIV>
<DIV class="pagebreak">
<H3 class="vartitle" id="LBXFOLSI">LBXFOLSI - Serum folate ( nmol/L)</H3>
<DL>
  <DT>Variable Name: </DT>
  <DD class="info">LBXFOLSI</DD>
  <DT>SAS Label: </DT>
  <DD>Serum folate ( nmol/L)</DD>
  <DT>English Text: </DT>
  <DD class="info">Serum folate ( nmol/L)</DD>
  <DT>Target: </DT>
  <DD> Both males and females 1 YEARS -			150 YEARS</DD></DL>
<TABLE class="values">
  <THEAD>
  <TR>
    <TH class="values" scope="column">Code or Value</TH>
    <TH class="values" scope="column">Value Description</TH>
    <TH class="values" scope="column">Count</TH>
    <TH class="values" scope="column">Cumulative</TH>
    <TH class="values" scope="column">Skip to Item</TH></TR></THEAD>
  <TBODY>
  <TR>
    <TD class="values" scope="row">5 to 474</TD>
    <TD class="values">Range of Values</TD>
    <TD align="right" class="values">8205</TD>
    <TD align="right" class="values">8205</TD>
    <TD class="values"></TD></TR>
  <TR>
    <TD class="values" scope="row">.</TD>
    <TD class="values">Missing</TD>
    <TD align="right" class="values">1102</TD>
    <TD align="right" class="values">9307</TD>
    <TD class="values"></TD></TR></TBODY></TABLE></DIV></DIV></DIV></BODY></HTML>
